Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ARDX
ARDX logo

ARDX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ardelyx Inc (ARDX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
6.140
1 Day change
2.59%
52 Week Range
8.400
Analysis Updated At
2026/03/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ardelyx Inc (ARDX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong positive catalysts including consistent analyst upgrades, a promising growth outlook, and extended intellectual property protection. Despite short-term technical and financial challenges, the long-term potential outweighs the risks.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 53.065, showing no overbought or oversold conditions. Moving averages are converging, suggesting a potential trend reversal. The stock is trading near its pivot point of 5.537, with resistance at 5.85 and support at 5.223.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
9

Positive Catalysts

  • Analysts have consistently raised price targets, with the highest target at $19, citing strong Ibsrela revenue growth and a promising pipeline. The company has secured a new patent extending IP protection to 2042, which supports long-term growth potential. Gross margin increased to 91.34%, reflecting operational efficiency.

Neutral/Negative Catalysts

  • Hedge funds are selling, with a 129.11% increase in selling activity over the last quarter. Financial performance in Q4 2025 showed a net income drop of -108.76% YoY and EPS decline to 0, which may raise concerns for some investors.

Financial Performance

In Q4 2025, revenue increased by 7.82% YoY to $125.2M, and gross margin improved by 8.39% to 91.34%. However, net income dropped significantly to -$407K, and EPS fell to 0, reflecting short-term financial challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are overwhelmingly positive, with multiple firms upgrading price targets and maintaining Buy or Strong Buy ratings. The highest price target is $19, reflecting confidence in the company's growth trajectory and market opportunities.

Wall Street analysts forecast ARDX stock price to rise
7 Analyst Rating
Wall Street analysts forecast ARDX stock price to rise
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 5.990
sliders
Low
10
Averages
14.86
High
19
Current: 5.990
sliders
Low
10
Averages
14.86
High
19
H.C. Wainwright
Buy
upgrade
$10 -> $18
AI Analysis
2026-02-20
Reason
H.C. Wainwright
Price Target
$10 -> $18
AI Analysis
2026-02-20
upgrade
Buy
Reason
H.C. Wainwright raised the firm's price target on Ardelyx to $18 from $10 and keeps a Buy rating on the shares. The firm is "encouraged" by the company having announced the successful new patent with expiration in November 2042.
TD Cowen
Buy
upgrade
$10 -> $13
2026-01-29
Reason
TD Cowen
Price Target
$10 -> $13
2026-01-29
upgrade
Buy
Reason
TD Cowen raised the firm's price target on Ardelyx to $13 from $10 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ARDX
Unlock Now

People Also Watch